1
/
of
0
FDA Drug Approval, N018602, CARDIZEM
FDA Drug Approval, N018602, CARDIZEM
Regular price
$89.00 USD
Regular price
Sale price
$89.00 USD
Unit price
/
per
NDA: 018602
Company: BAUSCH
Drug Name: CARDIZEM
Active Ingredients: DILTIAZEM HYDROCHLORIDE
Strength: 120MG
Dosage Form/Route: TABLET;ORAL
Action Date: 11/05/1982
Marketing Status: Prescription
Submission Classification: Type 1 - New Molecular Entity
Company: BAUSCH
Drug Name: CARDIZEM
Active Ingredients: DILTIAZEM HYDROCHLORIDE
Strength: 120MG
Dosage Form/Route: TABLET;ORAL
Action Date: 11/05/1982
Marketing Status: Prescription
Submission Classification: Type 1 - New Molecular Entity
Couldn't load pickup availability
- Status: Pending Fast-Track Request
- Delivery: Approximately 1 to 2 weeks when the FOIA office is operating at regular capacity
NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.
View full details